[go: up one dir, main page]

IT1163004B - Uso di una composizione emostatica a base di fattore settima e procedimento per preparare detta composizione - Google Patents

Uso di una composizione emostatica a base di fattore settima e procedimento per preparare detta composizione

Info

Publication number
IT1163004B
IT1163004B IT22056/82A IT2205682A IT1163004B IT 1163004 B IT1163004 B IT 1163004B IT 22056/82 A IT22056/82 A IT 22056/82A IT 2205682 A IT2205682 A IT 2205682A IT 1163004 B IT1163004 B IT 1163004B
Authority
IT
Italy
Prior art keywords
composition
prepare
factor
procedure
based hemostatic
Prior art date
Application number
IT22056/82A
Other languages
English (en)
Other versions
IT8222056A0 (it
Inventor
William R Thomas
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of IT8222056A0 publication Critical patent/IT8222056A0/it
Application granted granted Critical
Publication of IT1163004B publication Critical patent/IT1163004B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT22056/82A 1981-06-25 1982-06-24 Uso di una composizione emostatica a base di fattore settima e procedimento per preparare detta composizione IT1163004B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/277,469 US4382083A (en) 1981-06-25 1981-06-25 Therapeutic method for treating blood-clotting defects with factor VIIa

Publications (2)

Publication Number Publication Date
IT8222056A0 IT8222056A0 (it) 1982-06-24
IT1163004B true IT1163004B (it) 1987-04-08

Family

ID=23061015

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22056/82A IT1163004B (it) 1981-06-25 1982-06-24 Uso di una composizione emostatica a base di fattore settima e procedimento per preparare detta composizione

Country Status (11)

Country Link
US (1) US4382083A (it)
EP (1) EP0082182B1 (it)
JP (1) JPS58500994A (it)
BR (1) BR8207762A (it)
CA (1) CA1186994A (it)
DE (1) DE3276849D1 (it)
ES (1) ES513485A0 (it)
IT (1) IT1163004B (it)
MX (1) MX7191E (it)
WO (1) WO1983000016A1 (it)
ZA (1) ZA824233B (it)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501731A (en) * 1983-06-27 1985-02-26 Tishkoff Garson H Treatment of disparate bleeding disorders with factor X zymogen
ZA862768B (en) 1985-04-17 1986-12-30 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US5180583A (en) * 1985-11-26 1993-01-19 Hedner Ulla K E Method for the treatment of bleeding disorders
ATE66374T1 (de) * 1985-11-26 1991-09-15 Novo Nordisk As Zubereitungen und verfahren zur behandlung von blutungsstoerungen.
US6013531A (en) * 1987-10-26 2000-01-11 Dade International Inc. Method to use fluorescent magnetic polymer particles as markers in an immunoassay
FR2632524B1 (fr) * 1988-06-09 1992-03-13 Fondation Nale Transfusion San Procede de preparation d'une fraction concentree en facteur viia et son application a titre de medicament
US5677160A (en) * 1989-10-30 1997-10-14 Henkel Corporation Fat splitting process
US5583107A (en) * 1990-09-04 1996-12-10 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
US5597799A (en) * 1990-09-04 1997-01-28 Cor Therapeutics, Inc. Recombinant agents affecting thrombosis
US20040072757A1 (en) * 1990-09-04 2004-04-15 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
US5506134A (en) * 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5843442A (en) * 1990-10-22 1998-12-01 Corvas International, Inc. Blood coagulation protein antagonists and uses therefor
WO1993006855A1 (en) * 1991-10-11 1993-04-15 Novo Nordisk A/S Hemostatic composition for local hemostasis
CA2136633A1 (en) * 1992-06-12 1993-12-23 James D. Allbery, Jr. Intelligent process control communication system and method
MX9707930A (es) * 1995-05-31 1997-12-31 Henkel Corp Proceso mejorado para desdoblar grasas.
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
CZ81997A3 (en) * 1996-03-20 1997-10-15 Immuno Ag Pharmaceutical preparation for treating disorders connected with blood clotting, process of its preparation and use
WO1998044942A1 (de) 1997-04-08 1998-10-15 Baxter Aktiengesellschaft Immuntolerante prothrombinkomplex-präparation
US20050032690A1 (en) * 1997-09-10 2005-02-10 Rojkjaer Lisa Payne Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia
PT1820516E (pt) 1999-02-22 2013-10-31 Baxter Int Novas formulações de factor viii isentas de albumina
JP4676585B2 (ja) * 1999-12-24 2011-04-27 一般財団法人化学及血清療法研究所 血液凝固異常に基づく疾患の治療・予防用医薬組成物
US7015194B2 (en) * 2000-05-10 2006-03-21 Novo Nordisk A/S Pharmaceutical composition comprising factor VIIa and anti-TFPI
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
WO2003039579A1 (en) 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
US20030119743A1 (en) * 2001-11-09 2003-06-26 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors
EP1446150A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk Health Care AG Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors
US7291587B2 (en) 2001-11-09 2007-11-06 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
US7078479B2 (en) 2001-11-09 2006-07-18 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
KR20040065278A (ko) * 2001-12-21 2004-07-21 노보 노르디스크 에이/에스 변경된 인자 ⅶ 폴리펩티드의 액체 조성물
PL370652A1 (en) 2001-12-21 2005-05-30 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
US20030186862A1 (en) * 2002-04-02 2003-10-02 Nelsestuen Gary L. Factor VIIa compositions
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
DK2283856T3 (da) 2002-06-21 2017-11-20 Novo Nordisk Healthcare Ag Stabiliserede, faste sammensætninger af Faktor VIIa-polypeptider
AU2004222625A1 (en) * 2003-03-18 2004-09-30 Novo Nordisk Health Care Ag Liquid, aqueous, pharmaceutical compositions of factor VII polypeptides
US7897734B2 (en) * 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
JP5627832B2 (ja) * 2003-05-23 2014-11-19 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 溶液中におけるタンパク質の安定化
ES2335994T3 (es) * 2003-07-01 2010-04-07 Novo Nordisk Health Care Ag Composicion farmaceutica liquida, acuosa de polipeptidos factor vii.
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
AU2004298789A1 (en) * 2003-12-19 2005-06-30 Novo Nordisk Health Care Ag Stabilised compositions of factor VII polypeptides
BRPI0921429B1 (pt) * 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions

Also Published As

Publication number Publication date
DE3276849D1 (en) 1987-09-03
ES8304800A1 (es) 1983-04-01
WO1983000016A1 (en) 1983-01-06
JPH0428690B2 (it) 1992-05-15
JPS58500994A (ja) 1983-06-23
IT8222056A0 (it) 1982-06-24
ZA824233B (en) 1983-04-27
EP0082182A1 (en) 1983-06-29
EP0082182A4 (en) 1983-11-09
MX7191E (es) 1987-12-23
ES513485A0 (es) 1983-04-01
EP0082182B1 (en) 1987-07-29
BR8207762A (pt) 1983-05-31
US4382083A (en) 1983-05-03
CA1186994A (en) 1985-05-14

Similar Documents

Publication Publication Date Title
IT1163004B (it) Uso di una composizione emostatica a base di fattore settima e procedimento per preparare detta composizione
IT1164832B (it) Composizione a base di collageno riassorbibile per applicazioni mediche e procedimento di preparazione
IT8449330A0 (it) Composizione di gel interpolimero idrosolubile limpido,in particolareper uso cosmetico e procedimento di preparazione
BR8504174A (pt) Composicao restauradora dental fotopolimerizavel
MX160316A (es) Procedimiento para preparar una composicion terapeutica de accion prolongada a base de hidroxipropilmetilcelulosa
IT1193474B (it) Composizione per cemento dentario e processo di sua preparazione
IT1128225B (it) Blocco artificiale per strutture di protezione di opere marittime e procedimento per la sua fabbricazione
IT8467225A0 (it) Composti di solfonio procedimentodi preparazione di detti composti e composizioni farmacologiche contenenti i composti stessi
IT8519382A0 (it) Composizioni analgesiche e antiinfiammatorie comprendenti difeni dramina e metodi di usare le stesse
IT1188968B (it) Composizione stabile di s-adenosill-metionina e procedimento per prepararla
AU585662B2 (en) Settable compositions and methods of use thereof
BR8106767A (pt) Composicao elastomerica de organossiloxana e uso
IT8767787A0 (it) Composizione dentifricia in formadi gel
IT1116500B (it) Procedimento di preparazione ed uso di composti di 2-pirrolidone e prodotto ottenuto
IT1151945B (it) Disposizione di manopola odontoiatrica
KR880701524A (ko) 1-옥소히드로카르빌-치환 아자시클로헥산으로 되는 조성물 및 그의 용도
ES537051A0 (es) Procedimiento para preparar una composicion de organopolisiloxano
IT1090445B (it) Procedimento e composizione per la determinazione di idroperossidi
TR22145A (tr) Hidroksi-4-2h-1-benzotiopiron-2-one tuerevleri bunlarin hazirlanmasi ve kullanilmasi
DK270382A (da) Depotmaterialer deres fremstilling og anvendelse
IT1120627B (it) Composizione per protesi dentarie e procedimento di preparazione
MX161366A (es) Procedimiento para la preparacion de una formulacion de fotoactivadores solidos y la formulacion obtenida
IT1186761B (it) Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti
AR231920A1 (es) Una composicion dental opaca mejorada y procedimiento para prepararla
DK564886A (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970626